Pulse dexamethasone does not impair growth and body composition of very low birth weight infants.

References

• Frank L, Sosenko IRS: Undernutrition as a major contributing factor in the pathogenesis of bronchopulmonary dysplasia. Am Rev Respir Dis 138: 725–729, 1988.
   PubMedGoogle Scholar
• Wilson DC, McClure G, Halliday HL, Reid MMcC, Dodge JA: Nutrition and bronchopulmonary dysplasia. Arch Dis Child 66: 37–38, 1991.
   PubMedGoogle Scholar
• Morris HG: Mechanisms of glucocorticoid action in pulmonary disease. Chest 88: 133S–141S, 1985.
   Google Scholar
• Yoder MC, Chua R, Tepper R: Effect of dexamethasone on pulmonary inflammation and pulmonary function of ventilator-dependent infants with bronchopulmonary dysplasia. Am Rev Respir Dis 143: 1044–1048, 1991.
   PubMed Web of Science ®Google Scholar
• Cummings JJ, D'Eugenio DB, Gross SJ: A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med 320: 1505–1510, 1989.
   PubMed Web of Science ®Google Scholar
• Avery GB, Fletcher AB, Kaplan M, Brudno DS: Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics 75: 106–111, 1985.
   PubMed Web of Science ®Google Scholar
• Yeh TF, Torre JA, Rastogi A, Anyebuno MA, Pildes RS: Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: A double-blind, controlled study. J Pediatr 117: 273–282, 1990.
   PubMed Web of Science ®Google Scholar
• Harkavy KL, Scanlon JW, Chowdhry PK, Grylack LJ: Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants: A controlled trial. J Pediatr 115: 979–983, 1989.
   PubMed Web of Science ®Google Scholar
• Kari MA, Heinonen K, Ikonen RS, Koivisto M, Raivio KO: Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia. Arch Dis Child 68: 566–569, 1993.
   PubMed Web of Science ®Google Scholar
• Mammel MC, Green TP, Johnson DE, Thompson TR: Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet 1: 1356–1357, 1985.
   Google Scholar
• O'Neil EA, Chwals WJ, O'Shea MD, Turner CS: Dexamethasone treatment during ventilator dependency: possible life threatening gastrointestinal complications. Arch Dis Child 67: 10–11, 1992.
   PubMedGoogle Scholar
• Hyams JS, Moore RE, Leichtner AM, Carey DE, Goldberg BD: Relationship of type I procollagen to corticosteroid therapy in children with inflammatory bowel disease. J Pediatr 112: 893–898, 1988.
   PubMedGoogle Scholar
• Chesney RW, Mazess RB, Rose P, Jax DK: Effect of prednisone on growth and bone mineral content in childhood glomerular disease. Am J Dis Child 132: 768–772, 1978.
   PubMedGoogle Scholar
• Co E, Chari G, McCulloch K, Vidyasagar D: Dexamethasone treatment suppresses collagen synthesis in infants with bronchopulmonary dysplasia. Pediatr Pulmonol 16: 36–40, 1993.
   PubMedGoogle Scholar
• Ali NJ, Capewell S, Ward MJ: Bone turnover during high dose inhaled corticosteroid treatment. Thorax 46: 160–164, 1991.
   PubMed Web of Science ®Google Scholar
• Baron J, Huang Z, Oerter KE, Bacher JD, Cutler GB: Dexamethasone acts locally to inhibit longitudinal bone growth in rabbits. Am J Physiol 263-.E489-E492, 1992.
   Google Scholar
• Israel BA, Sherman FS, Guthrie RD: Hypertrophic cardiomyopathy associated with dexamethasone therapy for chronic lung disease in preterm infants. Am J Perinatol 10: 307–310, 1993.
   PubMedGoogle Scholar
• Wilson DM, Baldwin RB, Ariagno RL: A randomized, placebocontrolled trial of effects of dexamethasone on hypothalamic-pituitary-adrenal axis in preterm infants. J Pediatr 113: 764–768, 1988.
   PubMed Web of Science ®Google Scholar
• Pentikainen PJ: Pharmacological aspects of corticosteroid pulse therapy. Scand J Rheumatology 54 Suppl:6–9, 1984.
   Google Scholar
• Kimberley RP, Lockshin MD, Sherman RL, McDougal JS, Inman RD, Christian CL: High-dose intravenous methylprednisolone pulse therapy in systemic lupus erythematosus. Am J Med 70: 817–824, 1981.
   PubMed Web of Science ®Google Scholar
• Laxer KM, Stein LD, Petty RE: Intravenous pulse methylprednisolone treatment of juvenile dermatomyositis. Arthritis and Rheumatism 30: 328–334, 1987.
   PubMed Web of Science ®Google Scholar
• Miller JJ: Prolonged use of large intravenous steroid pulses in the rheumatic diseases of children. Pediatrics 65: 989–994, 1980.
   PubMed Web of Science ®Google Scholar
• Brozanski BS, Jones JG, Gilmour CH, Balsan MJ, Vazquez RL Israel BA, Newman B, Mimouni FB, Guthrie RD: Effects of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant. J Pediatr 126 769–776, 1995.
   PubMed Web of Science ®Google Scholar
• Ballard JL, Novak KK, Driver M: A simplified score for assessment of fetal maturation in newly born infants. J Pediatr 1979;95 769–774.
   PubMed Web of Science ®Google Scholar
• Pocock SJ: Methods of Randomization. In “Clinical Trials: A Practical Approach.” New York: John Wiley & Sons, pp 66–89 1983.
   Google Scholar
• Behnke AR, Wilmore JH: “Evaluation and regulation of body build and composition.” Prentice-Hall Inc: Englewood Cliffs, NJ 1974.
   Google Scholar
• VanLoan M, Mayclin P: A new TOBEC instrument and procedure for the assessment of body composition: use of Fournier coefficients to predict lean body mass and total body water. Am J Clin Nutr 45: 131–137, 1987.
   PubMedGoogle Scholar
• Fiorotto ML, Cochran WJ, Funk RC, Sheng HP, Klish WJ: Total body electrical conductivity measurements: effects of body com position and geometry. Am J Physiol 252: R794–R800, 1987.
   Google Scholar
• Cochran WJ, Klish WJ, Wong WW, Klein PD: Total body electrical conductivity used to determine body composition in infants Pediatr Res 20: 561–564, 1986.
   Google Scholar
• Mimouni F, Tsang RC: Bone mineral content: data analysis. Pediatrics 113: 178–180, 1988.
   Google Scholar
• Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM: Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 82: 527–532, 1988.
   PubMed Web of Science ®Google Scholar
• Widdowson EM, Dickerson JWT: Chemical composition of the body. In Comar CL, Bronner F (eds): “Mineral Metabolism,” Vol. 2. Orlando: Academic Press, pp 1–247, 1972.
   Google Scholar
• Greer FR, Lane J, Weiner S, Mazess RB: An accurate and reproducible absorptiometric technique for determining bone mineral content in newborn infants. Pediatr Res 17: 259–262, 1983.
   PubMedGoogle Scholar
• Greer FR, McCormick A: Improved bone mineralization and growth in premature infants fed fortified own mother's milk. J Pediatr 112: 961–969, 1988.
   PubMedGoogle Scholar
• Laan RFJM, Buijs WCAM, van Erning LJTO, Lemmens JAM, Corstens FHM, Ruijs SHJ, van de Putte LBA, van Riel PLCM: Differential effects of glucocorticoids on cortical appendicular and cortical vertebral bone mineral content. Calcif Tissue Int 52: 5–9, 1993.
   PubMed Web of Science ®Google Scholar
• Abrams SA, Schanler RJ, Hwai-Ping S, Evans HJ, Leblanc AD, Garza C: Bone mineral content reflects total body calcium in neonatal miniature piglets. Pediatr Res 24: 693–695, 1988.
   PubMedGoogle Scholar
• Venkataraman PS, Ahluwalia BW: Total bone mineral content and body composition by x-ray densitometry in newborns. Pediatrics 90: 767–770, 1992.
   PubMed Web of Science ®Google Scholar
• Gilman AG, Goodman LS, Gilman A (eds): “The Pharmacological Basis of Therapeutics,” 6th ed. New York: Macmillian, pp 1474–1477, 1980.
   Google Scholar
• Kurzner SI, Garg M, Bautista DB, Sargent CW, Bowman M, Keens TG: Growth failure in bronchopulmonary dysplasia: Elevated metabolic rates and pulmonary mechanics. J Pediatr 112: 73–80, 1988.
   PubMed Web of Science ®Google Scholar
• Carlos RQ, Seidler FJ, Slotkin TA: Fetal dexamethasone exposure alters macromolecular characteristics of rat brain development: a critical period for regionally selective alterations? Teratology 46: 45–59, 1992.
   PubMedGoogle Scholar
• Slotkin TA, Lappi SE, McCook EC, Tayyeb MI, Eylers JP, Seidler FJ: Glucocorticoids and the development of neuronal function: Effects of prenatal dexamethasone exposure on central noradrenergic activity. Biol Neonate 61: 326–336, 1992.
   PubMedGoogle Scholar